Allied Market Research
Loading...
0
New
New
2022
India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market

India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market by Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Recombinant Vaccines, and DNA Vaccines), Animal Type (Companion Animal, and Poultry), and Valence (Monovalent, and Multivalent): Opportunity Analysis and Industry Forecast, 2021––2030

A14825
Pages: 152
Dec 2021 | 497 Views
   
Author(s) : Linu Dash , Onkar Sumant
Tables: 79
Charts: 28
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market

Request Now !

The India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market was valued at $127,107.12 thousand in 2020, and is estimated to reach $229,987.00 thousand by 2030, growing at a CAGR of 6.1% from 2021 to 2030.

Vaccination is defined as an immunization process that decreases the disease burden in animals, and helps maintain animal health & welfare. Animal vaccination protects the domestic, wild animals, and poultry from highly contagious, infectious and deadly diseases such as parvovirus, rabies, hepatitis, and canine distemper. Animal vaccine aims to increase the production of poultry product in a cost-effective manner, enhance the health and welfare of companion animals, and prevent animal to human transmission from both wild life and domestic animals.  The combination of vaccines are used for the immunization of cats and dogs. 

India,-Bangladesh,-Sri-Lanka,-Nepal-Animal-Vaccine-Market

Get more information on this report : Request Sample Pages

The growth of the India, Bangladesh, Sri Lanka, Nepal animal vaccine market is majorly driven by increase in prevalence of infectious disease in animal, such as Foot and Mouth Disease (FMD), rabies, blue tongue, anthrax, and black quarter; increase in funding from private & government organizations for animal care centers; and advancements in animal vaccine product development by key manufacturers. For instance, in August 2021, the Punjab agriculture department, announced the ring vaccination of animals in the city of Ludhiana, India. Moreover, According to journal of One Health, in 2020, it was reported that around 500 animals died in Nepal due to rabies. Further, MSD Animal Health, one of the leading pharmaceutical companies, produces nobivac rabies, which is an inactivated vaccine administered for immunization of cats, and dogs, against rabies.

Moreover, surge in pet adoption is anticipated to fuel the growth of the animal vaccine market. In addition, rise in focus on pet health fuels the market growth, owing to the fact that poultry and companion animals are more vulnerable to develop infectious or fungal disease. Further, increase in demand for animal vaccination, and rise in concern about food security is anticipated to contribute toward the growth of the market. 

Furthermore, rise in awareness among individuals about the animal vaccination schedule is expected to provide remunerative opportunities for the expansion of the India, Bangladesh, Sri Lanka, Nepal animal vaccine market during the forecast period. Likewise, in May 2021, the Government of India, announced the launch of $1,690 million vaccination program for animals. Moreover, the presence of key manufacturing companies in India, Bangladesh, Sri Lanka, and Nepal and rise in spending on animal healthcare propel the growth of the market.

Thus, presence of various veterinary foundations and initiatives taken by government for organizing different vaccination programs propel the growth of the market. However, high cost of milk, egg and meat prices, due to increase in cost of animal vaccine, and adverse effect of vaccines on animal and human health are expected to restrict the market growth during the forecast period. The adverse effects of vaccine on animal health are anaphylaxis, systemic reaction, autoimmune hemolytic anemia, respiratory disease, and post vaccination sarcoma.

India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market Segmentation

The India, Bangladesh, Sri Lanka, Nepal animal vaccine market is segmented on the basis of type, animal type, valence, and country. By type, the market is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, recombinant vaccines, and DNA Vaccines. 

India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market
By Type

Your browser does not support the canvas element.

Attenuated Vaccines segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

On the basis of animal type, it is divided into companion animal, and poultry. Depending on valence, it is categorized into monovalent, and multivalent. Country wise, the market is analyzed across India, Bangladesh, Sri Lanka, and Nepal.

Segment Review

Depending on type, the attenuated vaccines segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to advancement in R&D activities in animal healthcare sector, and increase in prevalence of infectious disease in animal. However, the DNA vaccines segment is expected to witness considerable growth during the forecast period, owing to rise in prevalence of Newcastle disease, and surge in adoption of DNA vaccine.

India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market
By Animal type

Your browser does not support the canvas element.

Companion Animal segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

By animal type, the companion animals segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to increase in number of pet population, rise in pet adoption, initiative taken by government for vaccination of dogs and increase in prevalence of rabies. However, the poultry segment is expected to witness considerable growth during the forecast period, due to rise in the number of chicken production, and surge in demand for consumptions of poultry products such as milk, egg and meat.

On the basis of valence, the multivalent segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in demand for polyvalent vaccine, and rise in prevalence of disease in animals. However, the monovalent vaccine segment is expected to witness considerable growth during the forecast period, owing to increase in prevalence of infectious diseases in animal, surge in awareness about animal vaccine, and initiatives taken by governments and private organizations in order to promote immunization in animals.

India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market
By Valence

Your browser does not support the canvas element.

Multivalent segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

India garnered a major share in the India, Bangladesh, Sri Lanka, Nepal animal vaccine market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of infectious disease in animals, the presence of key players for manufacturing and developing animal vaccine, increase in number of animal population, and initiatives taken by government to vaccinate animals in the country. However, Bangladesh was the second largest contributor to the market in 2020 owing to increase in awareness about animal vaccination, rise in the demand for pet adoption, and presence of various veterinary foundations.

The key players operating in the India, Bangladesh, Sri Lanka, Nepal animal vaccine market include AniCon Labor Gmbh, Boehringer Ingelheim International GmbH, Cargill Animal Nutrition, Ceva Sante Animale, Hygieia Biological Laboratories, Intas Pharmaceutical Ltd, Merck KGAA, Romvac Company S.A, Sanofi, SavaVet, Vaxxinova Gmbh, Virbac S.A, Vivaldis, and Zoetis. 

India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market
By Country

2030
India 
Bangladesh
Sri Lanka
Nepal

India was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the India, Bangladesh, Sri Lanka, Nepal animal vaccine market, and the current trends & future estimations to elucidate imminent investment pockets.
  • It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Key Market Segments

  • By Type
    • Attenuated Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • Toxoid Vaccines
    • Recombinant Vaccines
    • DNA Vaccines
  • By Animal Type
    • Companion Animal
      • Dogs
      • Cats
    • Poultry
  • By Valence
    • Monovalent
    • Multivalent
  • By Country
    • India
    • Bangladesh
    • Sri Lanka
    • Nepal
  • KEY MARKET PLAYERS
    • AniCon Labor Gmbh
    • Boehringer Ingelheim International GmbH
    • Cargill Animal Nutrition
    • Ceva Sante Animale
    • Hygieia Biological Laboratories
    • Intas Pharmaceutical Ltd.
    • Merck KGAA
    • Romvac Company S.A
    • Sanofi
    • SavaVet
    • Vaxxinova Gmbh
    • Virbac S.A
    • Vivaldis
    • Zoetis
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top winning strategies

3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of disease in animal
3.5.1.2.Rise in animal healthcare expenditure
3.5.1.3.Increase in R&D activities for animal vaccine development
3.5.1.4.Growth in demand for pet insurance

3.5.2.Restraints

3.5.2.1.Highly competitive meat and milk prices
3.5.2.2.Adverse effect of veterinary vaccines on human and animal health

3.5.3.Opportunities

3.5.3.1.Advancement in vaccine products
3.5.3.2.Increase in demand for hybrid animal

3.5.4.Impact analysis

3.6.Impact analysis of COVID-19 on the India, Bangladesh, Sri Lanka, Nepal animal vaccine market
3.7.Pricing analysis
3.8.Per capital egg/meat consumption
3.9.Population of broilers/layers
3.10.Current vaccination coverage for different therapies

CHAPTER 4:INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Attenuated Vaccines

4.2.1.Key market trends, key growth factors and opportunities
4.2.2.Market size and forecast

4.3.Inactivated Vaccines

4.3.1.Key market trends, key growth factors and opportunities
4.3.2.Market size and forecast

4.4.Subunit Vaccines

4.4.1.Key market trends, key growth factors and opportunities
4.4.2.Market size and forecast

4.5.Toxoid Vaccines

4.5.1.Key market trends, key growth factors and opportunities
4.5.2.Market size and forecast

4.6.Recombinant Vaccines

4.6.1.Key market trends, key growth factors and opportunities
4.6.2.Market size and forecast

4.7.DNA Vaccines

4.7.1.Key market trends, key growth factors and opportunities
4.7.2.Market size and forecast

CHAPTER 5:INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY ANIMAL TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Companion animal

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast
5.2.3.Companion animal, by type

5.2.3.1.Market size and forecast
5.2.3.2.Dogs

5.2.3.2.1.Market size and forecast

5.2.3.3.Cats

5.2.3.3.1.Market size and forecast

5.3.Poultry

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast

CHAPTER 6:INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET,  BY VALENCE

6.1.Overview

6.1.1.Market size and forecast

6.2.Monovalent

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast

6.3.Multivalent

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast

CHAPTER 7:INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET,  BY COUNTRY

7.1.Overview

7.1.1.Market size and forecast

7.2.India

7.2.1.India animal vaccine market, by type
7.2.2.India animal vaccine market, by animal type
7.2.3.India animal vaccine market, by valence

7.3.Bangladesh

7.3.1.Bangladesh animal vaccine market, by type
7.3.2.Bangladesh animal vaccine market, by animal type
7.3.3.Bangladesh animal vaccine market, by valence

7.4.Sri Lanka

7.4.1.Sri Lanka animal vaccine market, by type
7.4.2.Sri Lanka animal vaccine market, by animal type
7.4.3.Sri Lanka animal vaccine market, by valence

7.5.Nepal

7.5.1.Nepal animal vaccine market, by type
7.5.2.Nepal animal vaccine market, by animal type
7.5.3.Nepal animal vaccine market, by valence

CHAPTER 8:COMPANY PROFILES

8.1.ANICON LABOR GMBH

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio

8.2.BOEHRINGER INGELHEIM INTERNATIONAL GMBH

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments

8.3.CARGILL ANIMAL NUTRITION

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio

8.4.CEVA SANTE ANIMALE

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Key strategic moves and developments

8.5.HYGIEIA BIOLOGICAL LABORATORIES

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio

8.6.INTAS PHARMACEUTICAL LTD

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio

8.7.MERCK KGAA

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance

8.8.ROMVAC COMPANY S.A

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Product portfolio

8.9.SANOFI

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance

8.10.SAVAVET

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio

8.11.VAXXINOVA GmbH

8.11.1.Company overview
8.11.2.Company snapshot
8.11.3.Operating business segments
8.11.4.Product portfolio

8.12.VIRBAC S.A

8.12.1.Company overview
8.12.2.Company snapshot
8.12.3.Operating business segments
8.12.4.Product portfolio
8.12.5.Business performance

8.13.VIVALDIS

8.13.1.Company overview
8.13.2.Company snapshot
8.13.3.Operating business segments
8.13.4.Product portfolio

8.14.ZOETIS

8.14.1.Company overview
8.14.2.Company snapshot
8.14.3.Operating business segments
8.14.4.Product portfolio
8.14.5.Business performance

LIST OF TABLES

TABLE 01.INDIA: ANIMAL VACCINES PRICES
TABLE 02.BANGLADESH: ANIMAL VACCINES PRICES
TABLE 03.SRI LANKA: ANIMAL VACCINES PRICES
TABLE 04.NEPAL: ANIMAL VACCINES PRICES
TABLE 05.PER CAPITAL EGG/MEAT CONSUMPTION (2020)
TABLE 06.NUMBER OF POPULATION OF BOILERS AND LAYERS CHICKENS (2019)
TABLE 07.VACCINE COVERAGE FOR DIFFERENT THERAPIES
TABLE 08.INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY TYPE, 2020–2030 ($THOUSANDS)
TABLE 09.INDIA ATTENUATED ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 10.INDIA INACTIVATED ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 11.INDIA SUBUNIT ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 12.INDIA TOXOID ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 13.INDIA RECOMBINANT ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 14.INDIA DNA ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 15.INDIA, BANGLADESH, SRI LANKA, NEPAL MARKET ANIMAL VACCINE MARKET, BY ANIMAL TYPE, 2020–2030 ($THOUSAND)
TABLE 16.INDIA COMPANION ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 17.COMPANION ANIMAL MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 18.VACCINATION FOR DOGS: CORE AND NON-CORE
TABLE 19.VACCINATION FOR CATS: CORE AND NON-CORE
TABLE 20.INDIA  POULTRY ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 21.INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY VALENCE, 2020–2030 ($THOUSAND)
TABLE 22.INDIA MONOVALENT ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 23.INDIA  MULTIVALENT ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 24.INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 25.INDIA ANIMAL VACCINE TYPE MARKET, 2020-2030 ($THOUSAND)
TABLE 26.INDIA ANIMAL VACCINE MARKET FOR ANIMAL TYPE, 2020-2030 ($THOUSAND)
TABLE 27.INDIA ANIMAL VACCINE MARKET, BY VALENCE, 2020-2030 ($THOUSAND)
TABLE 28.BANGLADESH ANIMAL VACCINE MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 29.BANGLADESH ANIMAL VACCINE MARKET FOR ANIMAL TYPE, 2020-2030 ($THOUSAND)
TABLE 30.BANGLADESH ANIMAL VACCINE MARKET, BY VALENCE, 2020-2030 ($THOUSAND)
TABLE 31.SRI LANKA ANIMAL TYPE VACCINE MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 32.SRI LANKA ANIMAL VACCINE MARKET FOR ANIMAL TYPE, 2020-2030 ($THOUSAND)
TABLE 33.SRI LANKA ANIMAL VACCINE MARKET FOR VALENCE, 2020-2030 ($MILLION)
TABLE 34.NEPAL ANIMAL TYPE VACCINE MARKET, 2020-2030 ($THOUSAND)
TABLE 35.NEPAL ANIMAL VACCINE MARKET FOR ANIMAL TYPE, 2020-2030 ($THOUSAND)
TABLE 36.NEPAL ANIMAL VACCINE MARKET, BY VALENCE, 2020-2030 ($THOUSAND)
TABLE 37.ANICON: COMPANY SNAPSHOT
TABLE 38.ANICON: OPERATING SEGMENT
TABLE 39.ANICON: PRODUCT PORTFOLIO
TABLE 40.BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 41.BOEHRINGER INGELHEIM: OPERATING SEGMENT
TABLE 42.BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 43.BOEHRINGER INGELHEIM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 44.CARGILL: COMPANY SNAPSHOT
TABLE 45.CARGILL: OPERATING SEGMENT
TABLE 46.CARGILL: PRODUCT PORTFOLIO
TABLE 47.CEVA: COMPANY SNAPSHOT
TABLE 48.CEVA: OPERATING SEGMENT
TABLE 49.CEVA: PRODUCT PORTFOLIO
TABLE 50.CEVA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 51.HYGIEIA: COMPANY SNAPSHOT
TABLE 52.HYGIEIA: OPERATING SEGMENT
TABLE 53.HYGIEIA: PRODUCT PORTFOLIO
TABLE 54.INTAS: COMPANY SNAPSHOT
TABLE 55.INTAS: OPERATING SEGMENT
TABLE 56.INTAS: PRODUCT PORTFOLIO
TABLE 57.MERCK: COMPANY SNAPSHOT
TABLE 58.MERCK: OPERATING SEGMENTS
TABLE 59.MERCK: PRODUCT PORTFOLIO
TABLE 60.ROMVAC: COMPANY SNAPSHOT
TABLE 61.ROMVAC: PRODUCT PORTFOLIO
TABLE 62.SANOFI: COMPANY SNAPSHOT
TABLE 63.SANOFI: OPERATING SEGMENT
TABLE 64.SANOFI: PRODUCT PORTFOLIO
TABLE 65.SAVAVET: COMPANY SNAPSHOT
TABLE 66.SAVAVET: OPERATING SEGMENT
TABLE 67.SAVAVET: PRODUCT PORTFOLIO
TABLE 68.VAXXINOVA: COMPANY SNAPSHOT
TABLE 69.VAXXINOVA: OPERATING SEGMENT
TABLE 70.VAXXINOVA: PRODUCT PORTFOLIO
TABLE 71.VIRBAC: COMPANY SNAPSHOT
TABLE 72.VIRBAC: OPERATING SEGMENT
TABLE 73.VIRBAC: PRODUCT PORTFOLIO
TABLE 74.VIVALDIS: COMPANY SNAPSHOT
TABLE 75.VIVALDIS: OPERATING SEGMENT
TABLE 76.VIVALDIS: PRODUCT PORTFOLIO
TABLE 77.ZOETIS: COMPANY SNAPSHOT
TABLE 78.ZOETIS: OPERATING SEGMENT
TABLE 79.ZOETIS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET SEGMENTATION
FIGURE 02.TOP WINNING STRATEGIES, BY YEAR, 2019–2021
FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019–2021
FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2019–2021
FIGURE 05.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.MODERATE THREAT OF SUBSTITUTES
FIGURE 08.HIGH THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE INTENSITY OF RIVALRY
FIGURE 10.TOP PLAYER POSITIONING, 2020
FIGURE 11.IMPACT ANALYSIS
FIGURE 12.ANIMAL VACCINES MARKET FOR DOGS, 2020–2030 ($THOUSAND)
FIGURE 13.ANIMAL VACCINES MARKET FOR CATS, 2020–2030 ($THOUSAND)
FIGURE 14.BOEHRINGER INGELHEIM: NET SALES, 2018–2020 ($MILLION)
FIGURE 15.BOEHRINGER INGELHEIM: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 16.BOEHRINGER INGELHEIM: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 17.MERCK: NET SALES, 2018–2020 ($MILLION)
FIGURE 18.MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 19.MERCK: REVENUE SHARE BY REGION, 2020(%)
FIGURE 20.SANOFI: NET SALES, 2018–2020 ($MILLION)
FIGURE 21.SANOFI: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 22.SANOFI: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 23.VIRBAC: NET SALES, 2018–2020 ($MILLION)
FIGURE 24.VIRBAC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 25.VIRBAC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 26.ZOETIS: NET SALES, 2018–2020 ($MILLION)
FIGURE 27.ZOETIS: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 28.ZOETIS: REVENUE SHARE, BY REGION, 2020 (%)

 
 

Growth of the India, Bangladesh, Sri Lanka, Nepal animal vaccine market is attributed to factors such as advancements in vaccine production for animal; rise in prevalence of infectious and contagious disease such as Newcastle Disease, Foot and Mouth Disease, Babesiosis, and Black Quarter (BQ); increase in funds from private & government organizations for development of various veterinary vaccination camps; and rise in awareness about pet vaccination schedule. The market is dependent on the requirement for animal derived food products such as meat & milk and the need of companion animals for safety of humans and companionship. It is observed that developed countries consume more animal-based food (rather than plant-based foods) as compared to the developing and the underdeveloped countries and spend more on pets, due to higher buying power. In addition, rise in pet adoption, and increase in key manufacturers for animal vaccine production, drive the growth of the market.

India is expected to witness the highest growth, in terms of revenue, owing to rise in the prevalence of infectious in animals, the presence of key players for manufacturing and developing animal vaccine, increase in number of animal population, and initiatives taken by government to vaccinate animals in the country.

Bangladesh was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to increase in awareness about animal vaccination, rise in the demand for pet adoption, and presence of various veterinary foundations.

However, high cost of milk, egg and meat, and adverse effects due to animal vaccine such as anaphylaxis, systemic reaction, autoimmune hemolytic anemia, respiratory disease, and post vaccination sarcoma are anticipated to restrain the market growth during the forecast period.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market is $127,107.12 thousand in 2020.

A. The forecast period in the report is from 2021 to 2030

A. The market value of India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market in 2021 was $135,025.89 thousand

A. The base year for the report is 2020.

A. Yes, India, Bangladesh, Sri Lanka, Nepal Animal Vaccine companies are profiled in the report

A. The top companies that hold the market share in India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market are AniCon Labor Gmbh, Boehringer Ingelheim International GmbH, Cargill Animal Nutrition, Ceva Sante Animale, Hygieia Biological Laboratories, Intas Pharmaceutical Ltd., Merck KGAA, Romvac Company S.A, Sanofi, SavaVet, Vaxxinova Gmbh, Virbac S.A, Vivaldis, and Zoetis

A. India is expected to register the highest CAGR from 2021 to 2030, owing to rise in the prevalence of infectious disease in animals such as Newcastle disease, and Marck’s disease, the presence of key players for manufacturing and developing animal vaccine, increase in number of animal population, and initiatives taken by government to vaccinate animals in the country

A. The key trends in the India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market are by alarming increase in the prevalence of animal disease, such as Foot and Mouth Disease (FMD), Black Quarter (BQ), Newcastle disease, Infectious Bursal Disease, and Fowl Pox; rise in government initiative for development of various programs to vaccinate animals; surge in number of pet and poultry population.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $2,374
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $2,638
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $4,088
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $4,431
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $7,179
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers